HLA-G and chronic myelogenous leukemia, BCR-ABL1 positive: Examples are systemic interferon (IFN)-α treatment that increased sHLA-G serum and sHLA-I plasma levels in melanoma and chronic myeloid leukemia (CML), respectively [52,75].